Patent · US Expired

Epothilone analogs

US6380394B1 · kind B1 · utility

54Cited by
0References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 1998
Grant dateApr 30, 2002
Priority date
Expiry dateJun 22, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel analogs of epothilone A, epothilone B, and epothilone C are synthesized by Stille coupling thazole-stannanes to macrolactone intermediates. The synthetic epothilone analogs selectively prevent mitosis in cancer cells through the induction and stabilization of microtubulin assembly. Selected synthetic epothilone analogs are demonstrated to have greater bioactivity than their corresponding native compound.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.